28063948|t|Cytokine IL-10, activators of PI3-kinase, agonists of α-2 adrenoreceptor and antioxidants prevent ischemia - induced cell death in rat hippocampal cultures
28063948|a|In the present work we compared the protective effect of anti-inflammatory cytokine IL-10 with the action of a PI3-kinase selective activator 740 Y-P, selective agonists of alpha-2 adrenoreceptor, guanfacine and UK-14,304, and compounds having antioxidant effect: recombinant human peroxiredoxin 6 and B27, in hippocampal cell culture during OGD (ischemia-like conditions). It has been shown that the response of cells to OGD in the control includes two phases. The first phase was accompanied by an increase in the frequency of spontaneous synchronous Ca(2+)-oscillations (SSCO) in neurons and Ca(2+) - pulse in astrocytes. Spontaneous Ca(2+) events in astrocytes during ischemia in control experiments disappeared. The second phase started after a few minutes of OGD and looked like a sharp/avalanche, global synchronic (within 20 s) increase in [Ca(2+)]i in many cells. Within 1 h after OGD, a mass death of cells, primarily astrocytes, was observed. To study the protective action of the compounds, cells were incubated in the presence of the neuroprotective agents for 10-40 min or 24 h before ischemia. All the neuroprotective agents delayed a global [Ca(2+)]i increase during OGD or completely inhibited this process and increased cell survival.
28063948	0	8	Cytokine	T116,T129	C0079189
28063948	9	14	IL-10	T116,T129	C0085295
28063948	16	26	activators	T121,T123	C0751968
28063948	30	40	PI3-kinase	T116,T126	C0044602
28063948	42	50	agonists	T121	C0243192
28063948	54	72	α-2 adrenoreceptor	T116,T192	C0034783
28063948	77	89	antioxidants	T121	C0003402
28063948	90	97	prevent	T080	C2700409
28063948	98	106	ischemia	T046	C0022116
28063948	109	116	induced	T169	C0205263
28063948	117	127	cell death	T043	C0007587
28063948	131	134	rat	T015	C0034693
28063948	135	146	hippocampal	T023	C0019564
28063948	147	155	cultures	T167	C3687726
28063948	192	209	protective effect	T080	C0205556
28063948	213	230	anti-inflammatory	T080	C1515999
28063948	231	239	cytokine	T116,T129	C0079189
28063948	240	245	IL-10	T116,T129	C0085295
28063948	255	261	action	T052	C3266814
28063948	267	277	PI3-kinase	T116,T126	C0044602
28063948	278	297	selective activator	T121,T123	C0751968
28063948	298	305	740 Y-P	T121	C1254351
28063948	307	325	selective agonists	T121	C0243192
28063948	329	351	alpha-2 adrenoreceptor	T116,T192	C0034783
28063948	353	363	guanfacine	T109,T121	C0079466
28063948	368	377	UK-14,304	T109,T121	C0147760
28063948	383	392	compounds	T121	C1254351
28063948	400	418	antioxidant effect	T039	C3179302
28063948	432	453	human peroxiredoxin 6	T116,T126	C1873178
28063948	458	461	B27	T121	C1254351
28063948	466	477	hippocampal	T023	C0019564
28063948	478	490	cell culture	T167	C3687726
28063948	491	501	during OGD	T043	C4236780
28063948	503	527	ischemia-like conditions	T033	C1317598
28063948	557	581	response of cells to OGD	T043	C4236780
28063948	589	596	control	T096	C0009932
28063948	610	616	phases	T079	C0205390
28063948	628	633	phase	T079	C0205390
28063948	656	664	increase	T169	C0442805
28063948	672	681	frequency	T079	C0439603
28063948	685	728	spontaneous synchronous Ca(2+)-oscillations	T043	C0600430
28063948	730	734	SSCO	T043	C0600430
28063948	739	746	neurons	T025	C0027882
28063948	751	757	Ca(2+)	T121,T196	C0596235
28063948	760	765	pulse	T039	C0391850
28063948	769	779	astrocytes	T025	C0004112
28063948	781	792	Spontaneous	T169	C0205359
28063948	793	799	Ca(2+)	T121,T196	C0596235
28063948	800	806	events	T051	C0441471
28063948	810	820	astrocytes	T025	C0004112
28063948	828	836	ischemia	T046	C0022116
28063948	840	859	control experiments	T096	C0009932
28063948	860	871	disappeared	T033	C0243095
28063948	884	889	phase	T079	C0205390
28063948	898	924	after a few minutes of OGD	T043	C4236780
28063948	943	958	sharp/avalanche	T033	C0243095
28063948	960	977	global synchronic	T033	C0243095
28063948	992	1000	increase	T169	C0442805
28063948	1005	1011	Ca(2+)	T121,T196	C0596235
28063948	1022	1027	cells	T025	C0007634
28063948	1040	1049	after OGD	T043	C4236780
28063948	1053	1072	mass death of cells	T043	C0007587
28063948	1084	1094	astrocytes	T025	C0004112
28063948	1123	1140	protective action	T080	C0205556
28063948	1148	1157	compounds	T121	C1254351
28063948	1159	1164	cells	T025	C0007634
28063948	1170	1179	incubated	T059	C1439852
28063948	1203	1225	neuroprotective agents	T121	C0242912
28063948	1255	1263	ischemia	T046	C0022116
28063948	1273	1295	neuroprotective agents	T121	C0242912
28063948	1296	1303	delayed	T079	C0205421
28063948	1314	1320	Ca(2+)	T121,T196	C0596235
28063948	1332	1342	during OGD	T043	C4236780
28063948	1346	1366	completely inhibited	T080	C0311403
28063948	1372	1379	process	T067	C1522240
28063948	1384	1393	increased	T081	C0205217
28063948	1394	1407	cell survival	T043	C0007620